menu
Showcases Stock ranks

Pfizer Inc. (PFE)
43.8 -0.77 (-1.73%) 12-14 16:03
Open: 44.08 Pre. Close: 44.57
High: 44.12 Low: 43.425
Volume: 31,333,031 Market Cap: 253185M
Share on Facebook   Tweet this page   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 44.172 - 44.404 44.404 - 44.602
Low: 42.864 - 43.13 43.13 - 43.356
Close: 43.413 - 43.865 43.865 - 44.249
Stock Technical Analysis
Overall:     
Target: Six months: 52.44
One year: 54.28
Support: Support1: 42.35
Support2: 35.24
Resistance: Resistance1: 44.90
Resistance2: 46.47
Pivot: 44.55
Moving Averages: MA(5): 44.20
MA(20): 44.29
MA(100): 42.93
MA(250): 38.93
MACD: MACD(12,26): 0.15
Signal(12,26,9): 0.25
%K %D: %K(14,3): 38.28
%D(3): 38.85
RSI: RSI(14): 47.40
52-Week: High: 46.47
Low: 33.2
Change(%): 17.9
Average Vol(K): 3-Month: 2340350
10-Days: 2624307
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.

PFE has closed above bottom band by 30.1%. Bollinger Bands are 24.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
2018-12-14T12:10:00-05:00
Pfizer Declares First-Quarter 2019 Dividend

2018-12-14T10:29:00-05:00
Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV(TM) (bevacizumab)

2018-12-14T08:00:00-05:00
Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older

Financial Analysis
Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 5780.47
Shares Float (M) 5766.67
% Held by Insiders
% Held by Institutions 112.70
Shares Short (K) 47356
Shares Short Prior Month (K)
Stock Financials
EPS 2.980
EPS Est. Current Year 2.560
EPS Est. Next Year 2.760
EPS Est. Next Quarter 0.560
Forward EPS 3.059
Book Value (p.s.) 3.650
PEG Ratio 2.02
Profit Margin 44.22
Operating Margin 28.35
Return on Assets (ttm) 14.1
Return on Equity (ttm) 36.3
Qtrly Rev. Growth
Gross Profit (p.s.) 1.807
Sales Per Share
EBITDA (p.s.) 0.620
Qtrly Earnings Growth 44.90
Operating Cash Flow (M) 17850.00
Levered Free Cash Flow (M) 15540.00
Stock Valuation
P/E 14.71
P/E Growth Ratio -0.02
P/BV 12.01
P/S 28099000320.00
P/CF 14.20
Dividend Yield 0.07
Dividends & Splits
Dividend 3.097
Dividend Pay Date 2018-12-03
Ex-Dividend Date 2018-11-08
Forward Dividend 1.360
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator